Live-long Medicine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Live-long Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live-long Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live-long Medicine Overall Market Size
2.1 Global Live-long Medicine Market Size: 2022 VS 2029
2.2 Global Live-long Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Live-long Medicine Players in Global Market
3.2 Top Global Live-long Medicine Companies Ranked by Revenue
3.3 Global Live-long Medicine Revenue by Companies
3.4 Top 3 and Top 5 Live-long Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Live-long Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Live-long Medicine Players in Global Market
3.6.1 List of Global Tier 1 Live-long Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Live-long Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Live-long Medicine Market Size Markets, 2022 & 2029
4.1.2 Chinese Herbal Medicine
4.1.3 Western Medicine
4.2 By Type - Global Live-long Medicine Revenue & Forecasts
4.2.1 By Type - Global Live-long Medicine Revenue, 2018-2023
4.2.2 By Type - Global Live-long Medicine Revenue, 2024-2029
4.2.3 By Type - Global Live-long Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Live-long Medicine Market Size, 2022 & 2029
5.1.2 Young People
5.1.3 Middle-aged People
5.1.4 Old People
5.2 By Application - Global Live-long Medicine Revenue & Forecasts
5.2.1 By Application - Global Live-long Medicine Revenue, 2018-2023
5.2.2 By Application - Global Live-long Medicine Revenue, 2024-2029
5.2.3 By Application - Global Live-long Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Live-long Medicine Market Size, 2022 & 2029
6.2 By Region - Global Live-long Medicine Revenue & Forecasts
6.2.1 By Region - Global Live-long Medicine Revenue, 2018-2023
6.2.2 By Region - Global Live-long Medicine Revenue, 2024-2029
6.2.3 By Region - Global Live-long Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Live-long Medicine Revenue, 2018-2029
6.3.2 US Live-long Medicine Market Size, 2018-2029
6.3.3 Canada Live-long Medicine Market Size, 2018-2029
6.3.4 Mexico Live-long Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Live-long Medicine Revenue, 2018-2029
6.4.2 Germany Live-long Medicine Market Size, 2018-2029
6.4.3 France Live-long Medicine Market Size, 2018-2029
6.4.4 U.K. Live-long Medicine Market Size, 2018-2029
6.4.5 Italy Live-long Medicine Market Size, 2018-2029
6.4.6 Russia Live-long Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Live-long Medicine Market Size, 2018-2029
6.4.8 Benelux Live-long Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Live-long Medicine Revenue, 2018-2029
6.5.2 China Live-long Medicine Market Size, 2018-2029
6.5.3 Japan Live-long Medicine Market Size, 2018-2029
6.5.4 South Korea Live-long Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Live-long Medicine Market Size, 2018-2029
6.5.6 India Live-long Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Live-long Medicine Revenue, 2018-2029
6.6.2 Brazil Live-long Medicine Market Size, 2018-2029
6.6.3 Argentina Live-long Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Live-long Medicine Revenue, 2018-2029
6.7.2 Turkey Live-long Medicine Market Size, 2018-2029
6.7.3 Israel Live-long Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Live-long Medicine Market Size, 2018-2029
6.7.5 UAE Live-long Medicine Market Size, 2018-2029
7 Live-long Medicine Companies Profiles
7.1 Shinkowa
7.1.1 Shinkowa Company Summary
7.1.2 Shinkowa Business Overview
7.1.3 Shinkowa Live-long Medicine Major Product Offerings
7.1.4 Shinkowa Live-long Medicine Revenue in Global Market (2018-2023)
7.1.5 Shinkowa Key News & Latest Developments
7.2 Herbalmax
7.2.1 Herbalmax Company Summary
7.2.2 Herbalmax Business Overview
7.2.3 Herbalmax Live-long Medicine Major Product Offerings
7.2.4 Herbalmax Live-long Medicine Revenue in Global Market (2018-2023)
7.2.5 Herbalmax Key News & Latest Developments
7.3 GeneHarbor (Hong Kong) Biotechnologies Limited
7.3.1 GeneHarbor (Hong Kong) Biotechnologies Limited Company Summary
7.3.2 GeneHarbor (Hong Kong) Biotechnologies Limited Business Overview
7.3.3 GeneHarbor (Hong Kong) Biotechnologies Limited Live-long Medicine Major Product Offerings
7.3.4 GeneHarbor (Hong Kong) Biotechnologies Limited Live-long Medicine Revenue in Global Market (2018-2023)
7.3.5 GeneHarbor (Hong Kong) Biotechnologies Limited Key News & Latest Developments
7.4 Angel Yeast
7.4.1 Angel Yeast Company Summary
7.4.2 Angel Yeast Business Overview
7.4.3 Angel Yeast Live-long Medicine Major Product Offerings
7.4.4 Angel Yeast Live-long Medicine Revenue in Global Market (2018-2023)
7.4.5 Angel Yeast Key News & Latest Developments
7.5 Xiamen Kingdomway Group Company
7.5.1 Xiamen Kingdomway Group Company Company Summary
7.5.2 Xiamen Kingdomway Group Company Business Overview
7.5.3 Xiamen Kingdomway Group Company Live-long Medicine Major Product Offerings
7.5.4 Xiamen Kingdomway Group Company Live-long Medicine Revenue in Global Market (2018-2023)
7.5.5 Xiamen Kingdomway Group Company Key News & Latest Developments
7.6 ABACHEM
7.6.1 ABACHEM Company Summary
7.6.2 ABACHEM Business Overview
7.6.3 ABACHEM Live-long Medicine Major Product Offerings
7.6.4 ABACHEM Live-long Medicine Revenue in Global Market (2018-2023)
7.6.5 ABACHEM Key News & Latest Developments
7.7 China Resources Double-Crane Pharmaceutical Co.,Ltd.
7.7.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Summary
7.7.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Business Overview
7.7.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Live-long Medicine Major Product Offerings
7.7.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Live-long Medicine Revenue in Global Market (2018-2023)
7.7.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.8 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
7.8.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Summary
7.8.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Business Overview
7.8.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Live-long Medicine Major Product Offerings
7.8.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Live-long Medicine Revenue in Global Market (2018-2023)
7.8.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.9 Hunan Er-Kang Pharmaceutical Co., Ltd.
7.9.1 Hunan Er-Kang Pharmaceutical Co., Ltd. Company Summary
7.9.2 Hunan Er-Kang Pharmaceutical Co., Ltd. Business Overview
7.9.3 Hunan Er-Kang Pharmaceutical Co., Ltd. Live-long Medicine Major Product Offerings
7.9.4 Hunan Er-Kang Pharmaceutical Co., Ltd. Live-long Medicine Revenue in Global Market (2018-2023)
7.9.5 Hunan Er-Kang Pharmaceutical Co., Ltd. Key News & Latest Developments
7.10 Brotek
7.10.1 Brotek Company Summary
7.10.2 Brotek Business Overview
7.10.3 Brotek Live-long Medicine Major Product Offerings
7.10.4 Brotek Live-long Medicine Revenue in Global Market (2018-2023)
7.10.5 Brotek Key News & Latest Developments
7.11 Xiwang Food
7.11.1 Xiwang Food Company Summary
7.11.2 Xiwang Food Business Overview
7.11.3 Xiwang Food Live-long Medicine Major Product Offerings
7.11.4 Xiwang Food Live-long Medicine Revenue in Global Market (2018-2023)
7.11.5 Xiwang Food Key News & Latest Developments
7.12 Teyi Pharmaceutical Group Co.,Ltd.
7.12.1 Teyi Pharmaceutical Group Co.,Ltd. Company Summary
7.12.2 Teyi Pharmaceutical Group Co.,Ltd. Business Overview
7.12.3 Teyi Pharmaceutical Group Co.,Ltd. Live-long Medicine Major Product Offerings
7.12.4 Teyi Pharmaceutical Group Co.,Ltd. Live-long Medicine Revenue in Global Market (2018-2023)
7.12.5 Teyi Pharmaceutical Group Co.,Ltd. Key News & Latest Developments
7.13 Bontac
7.13.1 Bontac Company Summary
7.13.2 Bontac Business Overview
7.13.3 Bontac Live-long Medicine Major Product Offerings
7.13.4 Bontac Live-long Medicine Revenue in Global Market (2018-2023)
7.13.5 Bontac Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Live-long Medicine Market Opportunities & Trends in Global Market
Table 2. Live-long Medicine Market Drivers in Global Market
Table 3. Live-long Medicine Market Restraints in Global Market
Table 4. Key Players of Live-long Medicine in Global Market
Table 5. Top Live-long Medicine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Live-long Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Live-long Medicine Revenue Share by Companies, 2018-2023
Table 8. Global Companies Live-long Medicine Product Type
Table 9. List of Global Tier 1 Live-long Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Live-long Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Live-long Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Live-long Medicine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Live-long Medicine Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Live-long Medicine Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Live-long Medicine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Live-long Medicine Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Live-long Medicine Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Live-long Medicine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Live-long Medicine Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Live-long Medicine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Live-long Medicine Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Live-long Medicine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Live-long Medicine Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Live-long Medicine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Live-long Medicine Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Live-long Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Live-long Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Live-long Medicine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Live-long Medicine Revenue, (US$, Mn), 2024-2029
Table 30. Shinkowa Company Summary
Table 31. Shinkowa Live-long Medicine Product Offerings
Table 32. Shinkowa Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 33. Shinkowa Key News & Latest Developments
Table 34. Herbalmax Company Summary
Table 35. Herbalmax Live-long Medicine Product Offerings
Table 36. Herbalmax Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 37. Herbalmax Key News & Latest Developments
Table 38. GeneHarbor (Hong Kong) Biotechnologies Limited Company Summary
Table 39. GeneHarbor (Hong Kong) Biotechnologies Limited Live-long Medicine Product Offerings
Table 40. GeneHarbor (Hong Kong) Biotechnologies Limited Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 41. GeneHarbor (Hong Kong) Biotechnologies Limited Key News & Latest Developments
Table 42. Angel Yeast Company Summary
Table 43. Angel Yeast Live-long Medicine Product Offerings
Table 44. Angel Yeast Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 45. Angel Yeast Key News & Latest Developments
Table 46. Xiamen Kingdomway Group Company Company Summary
Table 47. Xiamen Kingdomway Group Company Live-long Medicine Product Offerings
Table 48. Xiamen Kingdomway Group Company Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 49. Xiamen Kingdomway Group Company Key News & Latest Developments
Table 50. ABACHEM Company Summary
Table 51. ABACHEM Live-long Medicine Product Offerings
Table 52. ABACHEM Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 53. ABACHEM Key News & Latest Developments
Table 54. China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Summary
Table 55. China Resources Double-Crane Pharmaceutical Co.,Ltd. Live-long Medicine Product Offerings
Table 56. China Resources Double-Crane Pharmaceutical Co.,Ltd. Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 57. China Resources Double-Crane Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 58. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Summary
Table 59. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Live-long Medicine Product Offerings
Table 60. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 61. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 62. Hunan Er-Kang Pharmaceutical Co., Ltd. Company Summary
Table 63. Hunan Er-Kang Pharmaceutical Co., Ltd. Live-long Medicine Product Offerings
Table 64. Hunan Er-Kang Pharmaceutical Co., Ltd. Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 65. Hunan Er-Kang Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 66. Brotek Company Summary
Table 67. Brotek Live-long Medicine Product Offerings
Table 68. Brotek Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 69. Brotek Key News & Latest Developments
Table 70. Xiwang Food Company Summary
Table 71. Xiwang Food Live-long Medicine Product Offerings
Table 72. Xiwang Food Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 73. Xiwang Food Key News & Latest Developments
Table 74. Teyi Pharmaceutical Group Co.,Ltd. Company Summary
Table 75. Teyi Pharmaceutical Group Co.,Ltd. Live-long Medicine Product Offerings
Table 76. Teyi Pharmaceutical Group Co.,Ltd. Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 77. Teyi Pharmaceutical Group Co.,Ltd. Key News & Latest Developments
Table 78. Bontac Company Summary
Table 79. Bontac Live-long Medicine Product Offerings
Table 80. Bontac Live-long Medicine Revenue (US$, Mn) & (2018-2023)
Table 81. Bontac Key News & Latest Developments
List of Figures
Figure 1. Live-long Medicine Segment by Type in 2022
Figure 2. Live-long Medicine Segment by Application in 2022
Figure 3. Global Live-long Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Live-long Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Live-long Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Live-long Medicine Revenue in 2022
Figure 8. By Type - Global Live-long Medicine Revenue Market Share, 2018-2029
Figure 9. By Application - Global Live-long Medicine Revenue Market Share, 2018-2029
Figure 10. By Type - Global Live-long Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Live-long Medicine Revenue Market Share, 2018-2029
Figure 12. By Application - Global Live-long Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Live-long Medicine Revenue Market Share, 2018-2029
Figure 14. By Region - Global Live-long Medicine Revenue Market Share, 2018-2029
Figure 15. By Country - North America Live-long Medicine Revenue Market Share, 2018-2029
Figure 16. US Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Live-long Medicine Revenue Market Share, 2018-2029
Figure 20. Germany Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 21. France Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Live-long Medicine Revenue Market Share, 2018-2029
Figure 28. China Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. India Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Live-long Medicine Revenue Market Share, 2018-2029
Figure 34. Brazil Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Live-long Medicine Revenue Market Share, 2018-2029
Figure 37. Turkey Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Live-long Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. Shinkowa Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Herbalmax Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GeneHarbor (Hong Kong) Biotechnologies Limited Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Angel Yeast Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Xiamen Kingdomway Group Company Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. ABACHEM Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. China Resources Double-Crane Pharmaceutical Co.,Ltd. Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hunan Er-Kang Pharmaceutical Co., Ltd. Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Brotek Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Xiwang Food Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Teyi Pharmaceutical Group Co.,Ltd. Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Bontac Live-long Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
